Skip to search formSkip to main contentSkip to account menu

Dibekacin

Known as: 3',4' Dideoxykanamycin B, B, 3',4'-Dideoxykanamycin, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-2-deoxy- 
An aminoglycoside antibiotic derived from kanamycin B. Dibekacin is active against bacterial strains that are resistant to kanamycin.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
BackgroundThe present study was undertaken to examine whether antibiotic-impregnated calcium phosphate cement (CPC) would provide… 
1997
1997
A distinct family of major histocompatibility complex (MHC) class I genes has recently been identified within the human MHC… 
1987
1987
Four multiband compression limiters and two linear amplification systems were compared in terms of the intelligibility of… 
1987
1987
Four multiband compression limiters and two linear amplification systems were compared in terms of the intelligibility of… 
1978
1978
Against sulbenicillin- and gentamicin-susceptible strains of Pseudomonas aeruginosa, SCE-129 was about 10 times more active than… 
1977
1977
In investigations on the action of DKB (3' 4'‐dideoxykanamycin B), an aminoglycoside type drug, on the inner ears of mice and… 
1975
1975
Sir: As reported previously,1-5) aminoglycoside 6'-N-acetyltransferases [AAC(6')] in R factorcarrying Escherichia coli and… 
1971
1971
Sir: As described in the preceding communi-cation1), 3' , 4/-dideoxykanamycin B (DKB) was inactivated in the presence of ATP by… 
1970
1970
Partially purified fractions of the water-soluble extract of Entamoeba histolytica (DKB strain) obtained by chromatography in…